SecBot SecBot
144 ·Filed Nov 16, 2026

VRTX

VERTEX PHARMACEUTICALS INC / MA
NEUTRAL
Impact 2/10
Horizondays Processed1d 3h ago SEC0001959173-26-008021
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a standard advance notice for a small insider sale by a director. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizondays
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vertex Pharmaceuticals director Nancy Thornberry filed a Form 144 notice of intent to sell 1,000 shares of common stock, with an estimated aggregate market value of approximately $547,860 based on the filing. The shares were acquired through restricted stock vesting in December 2024 and May 2025. This is a routine, small disposition relative to the company's $137.6B market cap and the director's likely total holdings.

Key Facts

  • Nancy Thornberry, a director of Vertex Pharmaceuticals, filed a Form 144 on November 16, 2026.
  • The proposed sale is for 1,000 shares of common stock.
  • Estimated aggregate market value of the sale is $547,860.
  • Shares were acquired via restricted stock vesting on December 5, 2024 (499 shares) and May 1, 2025 (501 shares).
  • The sale is planned for execution on or after November 16, 2026, through Fidelity Brokerage Services LLC.

Financial Impact

Proceeds of approximately $547,860, representing about 0.0004% of Vertex's $137.6B market cap.

Risk Factors

  • The sale may not be executed; Form 144 is an intent to sell, not a completed transaction.
  • No unusual insider selling pattern detected; this appears to be a routine portfolio diversification move.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-008021
Document: 0001959173-26-008021-index.html0001959173-26-008021
Document: 0001959173-26-008021.txt0001959173-26-008021

Track record

21 reports on VRTX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.87% at T+60 after the Feb 25, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $537.79 Now $531.45 −1.18% settles Nov 24
  2. Nov 16, 20261d ago 144 Neutral 2/10 Viewing Entry $543.10 Now $531.45 −2.15% settles Nov 23
  3. Nov 16, 20261d ago 144 Neutral 1/10 Entry $544.98 Now $531.45 −2.48% settles Nov 23
  4. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $542.00 Now $531.45 −1.95% settles Nov 23
  5. Nov 12, 20265d ago 144 Neutral 2/10 Entry $542.62 Now $531.45 −2.06% settles Nov 19
  6. Nov 6, 202611d ago 144 Neutral 2/10 Entry $547.09 to $538.60 Now $531.45 −2.86% ▼ −1.55% −4.15% vs SPY
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $530.76 to $547.89 Now $531.45 +0.13% ▲ +3.23% +3.81% vs SPY
  8. Oct 22, 202626d ago 3 Neutral 2/10 Entry $523.93 to $558.88 Now $531.45 +1.44% ▲ +6.67% +7.23% vs SPY
  9. Oct 20, 202628d ago 8-K Neutral 2/10 Entry $524.52 to $521.03 Now $531.45 +1.32% ▼ −0.67% −0.22% vs SPY
  10. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $500.36 to $517.49 Now $531.45 +6.21% ▲ +3.42% +3.57% vs SPY
Showing 10 of 21

US Market Status

Market Open · Closes in 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026